Resilience to manufacture mRNA for Moderna in Canada
National Resilience, Inc. will manufacture drug substance for Moderna’s COVID-19 vaccine from its facility in Mississauga, Ontario.
Archives for September 8, 2021
Sandoz in oncology biosimilar deal with China’s Bio-Thera
Biosimilar producer, Sandoz, has entered into a commercialization agreement for biosimilar, BAT1706, referencing Avastin (bevacizumab) with Bio-Thera Solutions for the treatment of multiple types of cancers.
Japan to take 150m doses of Takeda-produced Novavax shots, probe ongoing into deaths following inoculation with recalled Moderna vaccine lot
Japan’s health ministry is to secure 150 million doses of Novavax’ vaccine candidate that Takeda is producing. The Japanese government's purchasing agreement is subject to regulatory approvals.
Avantor to acquire Masterflex, strengthening offer across bioproduction platforms
Avantor will acquire Masterflex, a manufacturer of peristaltic pumps and aseptic single-use fluid transfer technologies, in a $2.9bn deal.
Building a biotech hub: Switzerland puts the focus on personalized medicine, mRNA, CGT and more
Switzerland wants to build on the momentum of recent years to get ahead in key areas for the future.